Mirae’s lithium product; Active gets a bid; UBS is still bullish; Jamie Dimon’s faux pas; Are we in an equity bubble? Inflation, what inflation; Money for the next generation; Advertising and much more.

Mirae’s lithium product; Active gets a bid; UBS is still bullish; Jamie Dimon’s faux pas; Are we in an equity bubble? Inflation, what inflation; Money for the next generation; Advertising and much more.
The two firms have launched a nutrition themed product.
This week FSA presents a quick comparison of two mixed asset products: the Blackrock GF Global Multi-Asset Income Fund and the JP Morgan Multi Income Fund.
Indosuez poaches from DBS; Stanchart taps Swiss PB; DBWM attracts veteran banker; UBS hires tech specialists; State Street has new regional leadership roles; Pictet WM appoints Asia CIO: JPMAM relocates insurance head.
This week FSA presents a quick comparison of two Emerging Markets Equity products: the JP Morgan Emerging Markets Equity Fund and the Schroder Emerging Markets Fund.
Stressed-out junior bankers want a better work/life balance.
Schroders’ Apac boss; EFG poaches; ChinaAMC’s ETF head; Nomura spends; Raffles FO in Beijing; JPMAM has new Oz chief.
Blackrock on China; JP Morgan’s private Bitcoin; State Street shuns Americans; SPAC madness; Howard Marks’s warnings; Making predictions; Advertising from Fidelity and Lion Global; and much more.
Indosuez poaches from HSBC; DWS hires Apac client head; UBS vet joins HSBC; Schroders’ sustainable future; CS hires more; Citi strengthens family office business; BNY Mellon has Southeast Asia intermediary head; JPMAM’s data science leader; Fidelity’s changes in Japan.
Franklin Templeton appoints Apac chair; Barclays taps UBS; JPM hires trust head; Blackrock’s renewable power MD; CS bond head moves to boutique; Citi promotion and hire; Ninety One expands EM fixed income team; Crux adds to Asian equities.
Part of Mark Allen.